title: Re: estrogen-progestin replacement therapy and endometrial cancer.
authors.forename: B
authors.initials: B
authors.lastname: McKnight
authors.forename: L F
authors.initials: LF
authors.lastname: Voigt
authors.forename: S A
authors.initials: SA
authors.lastname: Beresford
authors.forename: N S
authors.initials: NS
authors.lastname: Weiss
mesh_terms: D004334:Drug Administration Schedule; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000517:prevention & control*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D016017:Odds Ratio; D011372:Progestins / Q000008:administration & dosage*; D012306:Risk; D012307:Risk Factors
chemical_list: D004967:Estrogens; D011372:Progestins